ACRES Commercial Realty Corp. (ACR) · Nov 6, 2026 · Material agreement
Facility extended — $250M facility extended to Nov. 3, 2027; coverage floor lowered to 1.15x
ACRES Commercial Realty’s debt facility now runs through 2027, but the amendment also relaxes key financial covenants as credit costs rise.
ACRES is a commercial mortgage REIT in the middle of an internalization and balance-sheet reset: it now combines CRE lending with investment management and insurance, while its September 30 portfolio carried $2.1 billion of loans, $96.2 million of liquidity and 2.7x GAAP leverage. The filing protects funding runway. Morgan Stanley agreed to extend the $250 million repurchase facility’s termination date by one year, from November 3, 2026 to November 3, 2027. The extension matters because ACR remains dependent on warehouse and repurchase financing to originate and carry CRE loans, even as management says it is pursuing a more capital-preservation-oriented balance sheet.
| Metric | Current | Prior / comparison |
|---|---|---|
| Facility termination date (Master Repurchase Agreement) | Nov. 3, 2027 | Nov. 3, 2026 |
| Facility amount (Definitions) | $250M | — |
| Minimum EBITDA / interest expense (Guaranty, Section 9) | 1.15x | 1.35x prior schedule |
The price of that runway is covenant relief. The amendment lowers the minimum EBITDA-to-interest test to 1.15x for the period beginning with the September 30, 2026 quarter, versus the prior 1.35x step-up. That is supportive for near-term compliance, but it also signals that the lender and borrower are resetting the test around weaker earnings capacity after a quarter with a $56.3 million GAAP loss and an $8.3 million credit-loss provision.
Bottom line: This is modestly helpful rather than a clean operational win: ACR gets another year of secured financing and more breathing room under its coverage covenant, but the need to loosen that covenant confirms pressure in the balance-sheet story.apelextensions make the company’s transition more financeable; they do not by themselves improve credit performance or earnings. Bottom line: This is modestly helpful rather than a clean operational win: ACR gets another year of secured financing and more breathing room under its coverage covenant, but the need to loosen that covenant confirms pressure in the balance-sheet story. The amendment makes the company’s transition more financeable; it does not by itself improve credit performance or earnings.
Q4 2026 results and year-end covenant testing
A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.
A buy-side analyst on every ticker — the whole market decoded the second it moves, before it's a headline. Free gives you a taste. Pro takes the cap off and opens the full read on every company.
by Signing in NOW, claim your FREE 14-day Pro trial!